Medical device developer DFine has received U.S. Food and Drug Administration (FDA) 510(k) clearance for a percutaneous radiofrequency ablation (RFA) device.
The product performs localized tumor necrosis of vertebral body lesions where metastatic disease has spread to the spine and caused severe pain and discomfort, according to the San Jose, CA-based firm.
Copyright © 2010 AuntMinnie.com